Optimization of chemical induction conditions for human herpesvirus 8 (HHV-8) reactivation with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) from latently-infected BC-3 cells

Biologicals

Volumn 39, Issue 3, 2011, Pages 158-166

  Ma, Wenbin ^a   Galvin, Teresa A ^a   Ma, Hailun ^a   Ma, Yunkun ^a,b   Muller, Jacqueline ^b   Khan, Arifa S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

BC 3 cells; Chemical induction; HHV 8 reactivation; Latent virus; TPA

Indexed keywords

HISTONE DEACETYLASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CELL CYCLE S PHASE; CELL GROWTH; CELL SYNCHRONIZATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; VIRUS INDUCTION; VIRUS PARTICLE; VIRUS REACTIVATION; VIRUS REPLICATION;

BASE SEQUENCE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DNA, VIRAL; HERPESVIRUS 8, HUMAN; HISTONE DEACETYLASES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; RNA, MESSENGER; RNA, VIRAL; TETRADECANOYLPHORBOL ACETATE; VIRUS ACTIVATION; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 8;

EID: 79957528894     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.03.001     Document Type: Article

References (55)

1. Moore P.S., Gao S.J., Dominguez G., Cesarman E., Lungu O., Knowles D.M., et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 1996, 70:549-558.
2. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
3. Chang Y., Moore P.S., Talbot S.J., Boshoff D.H., Zarkowska T., Godden-Kent D., et al. Cyclin encoded by KS herpesvirus. Nature 1996, 382:410.
4. Offermann M.K. HHV-8: a new herpesvirus associated with Kaposi's sarcoma. Trends Microbiol 1996, 4:383-386.
5. Rady P.L., Yen A., Martin R.W., Nedelcu I., Hughes T.K., Tyring S.K. Herpesvirus-like DNA sequences in classic Kaposi's sarcomas. J Med Virol 1995, 47:179-183.
6. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191.
7. Cannon J.S., Ciufo D., Hawkins A.L., Griffin C.A., Borowitz M.J., Hayward G.S., et al. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 2000, 74:10187-10193.
8. Arvanitakis L., Mesri E.A., Nador R.G., Said J.W., Asch A.S., Knowles D.M., et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of epstein-barr virus. Blood 1996, 88:2648-2654.
9. Gaidano G., Pastore C., Gloghini A., Cusini M., Nomdedeu J., Volpe G., et al. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 1996, 10:941-949.
10. Dupin N., Diss T.L., Kellam P., Tulliez M., Du M.Q., Sicard D., et al. HHV-8 is associated with a plasmablastic variant of castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000, 95:1406-1412.
11. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 1999, 96:4546-4551.
12. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
13. Grundhoff A., Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 2004, 113:124-136.
14. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., et al. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and epstein-barr virus in dually infected body cavity lymphoma cells. J Virol 1997, 71:314-324.
15. Radkov S.A., Kellam P., Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000, 6:1121-1127.
16. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998, 394:588-592.
17. Fujimuro M., Wu F.Y., ApRhys C., Kajumbula H., Young D.B., Hayward G.S., et al. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 2003, 9:300-306.
18. Lu M., Suen J., Frias C., Pfeiffer R., Tsai M.H., Chuang E., et al. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir. J Virol 2004, 78:13637-13652.
19. Renne R., Lagunoff M., Zhong W., Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 1996, 70:8151-8154.
20. Zoeteweij J.P., Rinderknecht A.S., Davis D.A., Yarchoan R., Blauvelt A. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines. J Med Virol 2002, 66:378-383.
21. Calderwood M., White R.E., Griffiths R.A., Whitehouse A. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal peristence. J Gen Virol 2005, 86:2703-2708.
22. Jung J.U., Stager M., Desrosiers R.C. Virus-encoded cyclin. Mol Cell Biol 1994, 14:7235-7244.
23. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., et al. Viral FLICE-inhibitory protein (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386:517-521.
24. Paulose-Murphy M., Ha N.K., Xiang C., Chen Y., Gillim L., Yarchoan R., et al. Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol 2001, 75:4843-4853.
25. Yu Y., Black J.B., Goldsmith C.S., Browning P.J., Bhalla K., Offermann M.K. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 1999, 80(Pt 1):83-90.
26. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996, 2:342-346.
27. Lukac D.M., Renne R., Kirshner J.R., Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 1998, 252:304-312.
28. Sun R., Lin S.-F., Gradoville L., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 1998, 95:10866-10871.
29. Xu Y., AuCoin D.P., Huete A.R., Cei S.A., Hanson L.J., Pari G.S. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J Virol 2005, 79:3479-3487.
30. Gradoville L., Kwa D., El-Guindy A., Miller G. Protein kinase C-independent activation of the epstein-barr virus lytic cycle. J Virol 2002, 76:5612-5626.
31. Wang Y., Chong O.T., Yuan Y. Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus. Virology 2004, 325:149-163.
32. Xie J., Ajibade A.O., Ye F., Kuhne K., Gao S.J. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 2008, 371:139-154.
33. Ye J., Shedd D., Miller G. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 p.omoter mediates lytic cycle induction by butyrate. J Virol 2005, 79:1397-1408.
34. Chiou C.J., Poole L.J., Kim P.S., Ciufo D.M., Cannon J.S., ap Rhys C.M., et al. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 2002, 76:3421-3439.
35. Haque M., Chen J., Ueda K., Mori Y., Nakano K., Hirata Y., et al. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J Virol 2000, 74:2867-2875.
36. Haque M., Ueda K., Nakano K., Hirata Y., Parravicini C., Corbellino M., et al. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 p.otein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J Gen Virol 2001, 82:1175-1180.
37. McAllister S.C., Hansen S.G., Messaoudi I., Nikolich-Zugich J., Moses A.V. Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase. J Virol 2005, 79:2626-2630.
38. Ye J., Gradoville L., Daigle D., Miller G. De novo protein synthesis is required for lytic cycle reactivation of epstein-barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. J Virol 2007, 81:9279-9291.
39. Khan A.S. Characterization and qualification of cell substrates for manufacturing viral vaccines in the United States. Bioprocessing 2009, 8:8-12.
40. Khan A.S., Ma W., Ma Y.K., Kumar A., Williams D.K., Muller J., et al. Proposed algorithm to investigate latent and occult viruses in vaccine cell substrates by chemical induction. Biologicals 2009, 37:196-201.
41. Paul J. Growth characteristics of established cell lines 1970, Churchill Livingstone, Edinburgh. 4th ed.
42. Krishnan H.H., Naranatt P.P., smith M.S., Zeng L., Bloomer C., Chandran B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 2004, 78:3601-3620.
43. Gregory T.R. Animal genome size database 2005, http://www.genomesize.com.
44. Khan A.S., Sears J.F., Muller J., Galvin T.A., Shahabuddin M. Sensitive assays for isolation and detection of simian foamy retroviruses. J Clin Microbiol 1999, 37:2678-2686.
45. Jenner R.G., Alba M.M., Boshoff C., Kellam P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 2001, 75:891-902.
46. Fiore M., Zanier R., Degrassi F. Reversible G1 arrest by dimethyl sulfoxide as a new method to synchronize chinese hamster cells. Mutagenesis 2002, 17:419-424.
47. Hashem M.A., Bhandari D.P., Kang S.K., Lee B.C., Suk H.W. Cell cycle analysis of in vitro cultured goral (Naemorhedus caudatus) adult skin fibroblasts. Cell Biol Int 2006, 30:698-703.
48. Boshoff C., Schulz T.F., Kennedy M.M., Graham A.K., Fisher C., Thomas A., et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995, 1:1274-1278.
49. Ballestas M.E., Chatis P.A., Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999, 284:641-644.
50. Lacoste V., Judde J.G., Bestett G., Cadranel J., Antoine M., Valensi F., et al. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses. Leuk Lymphoma 2000, 38:401-409.
51. Lan K., Kuppers D.A., Verma S.C., Sharma N., Murakami M., Robertson E.S. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol 2005, 79:7453-7465.
52. Lu F., Zhou J., Wiedmer A., Madden K., Yuan Y., Lieberman P.M. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 p.omoter correlates with reactivation from latency. J Virol 2003, 77:11425-11435.
53. Sakurada S., Katano H., Sata T., Ohkuni H., Watanabe T., Mori S. Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission. J Virol 2001, 75:7717-7722.
54. Barbera A.J., Chodaparambil J.V., Kelley-Clarke B., Joukov V., Walter J.C., Luger K., et al. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 2006, 311:856-861.
55. Stedman W., Deng Z., Lu F., Lieberman P.M. Orc, Mcm, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol 2004, 78:12566-12575.